Navigation Links
Herley Reports 4th Quarter and Year-End Results
Date:10/11/2007

ned earnings 99,404 96,286

Treasury stock, 798,567 common shares,

at cost - (9,044)

Accumulated other comprehensive income 1,745 1,344

-------- ---------

Total Shareholders' Equity 209,641 203,470

-------- ---------

Total Liabilities and

Shareholders' Equity $262,593 $251,450

-------- ---------

HERLEY INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands except per share data)

Thirteen weeks Fifty-two weeks

ended ended

-------------- ---------------

July 29, July 30, July 29, July 30,

2007 2006 2007 2006

-------- -------- -------- --------

Net sales $40,626 $42,802 $163,140 $176,268

-------- -------- -------- --------

Cost and expenses:

Cost of products sold 29,306 33,021 118,834 127,921

Selling and administrative

expenses 8,875 9,181 34,190 34,966

Employment contract settlement

costs - - 8,914 -

-------- -------- -------- --------


'/>"/>

SOURCE Herley Industries, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...edical university Karolinska Institutet have deter...ential for the interaction between the mammalian e...ure , gives a first glimpse into the molecular arc...ications for the future of human reproductive medi...aceptives. , The beginning of every new life sta...
(Date:12/4/2008)...4 AARP CEO Bill Novelli...n to the latest Congressional efforts to help fail...com.com/cgi-bin/prnh/20070209/NYF043LOGO ) , ... get worse if we allow America,s biggest automaker...g these corporations go under -- taking with them ...
(Date:12/4/2008)...ewswire/ -- Getting back in the gym and,erasing y...arge amounts of,weight because your health depend...a,s #1 Selling Protein*, is joining forces with NB... help contestants and viewers retake control of,t...t, The Biggest Loser,Protein by DESIGNER WHEY, wh...
(Date:12/4/2008)...swire/ -- Qforma, an advanced analytics and predi...tment of Kent Harris as Senior Vice President of S...egarded in the pharmaceutical industry and is an i... Kelly D. Myers, CEO of Qforma. "He brings nearly ...ve record of measurable results. His success in sa...
Breaking Medicine News(10 mins):Health News:Crystallography reveals the 3-D structure of mammalian sperm receptor 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 2Health News:AARP: Health Care and Pension Reform Critical to Economic Recovery 3Health News:DESIGNER WHEY to Help Contestants and Fans of NBC's The Biggest Loser Shed Pounds 2Health News:DESIGNER WHEY to Help Contestants and Fans of NBC's The Biggest Loser Shed Pounds 3Health News:DESIGNER WHEY to Help Contestants and Fans of NBC's The Biggest Loser Shed Pounds 4Health News:Qforma Appoints Kent Harris as Senior Vice President of Sales 2
...men who had suffered from postpartum depression an...g able to lose weight. A new study by scientists o... tells that it is possible to lose weight and stil...r a long time antidepressants to be taken for post...
...tration (FDA) of US had warned the public and medi...roadly called as atypical antipsychotic drugs on e...zole, olanzapine, quetiapine, risperidone, clozapi...he clinical treatment of schizophrenia and mania. ...
...ennium Ecosystem Assessment, scientists have said ... are having a detrimental effect to human health a...es such as malaria and cholera are threatening to ...s are emerging because of 60% of the beneficial fa...
...8 diabetic patients and 799 non-diabetic women vol...s of Epidemiologic Research and Information Center...es the risk of having a urinary tract infection fo...The researchers have done two annual follow up of ...
Other Medicine News:
(Date:12/2/2008)...ire/ -- Horizon Therapeutics, Inc., a,privately h...t two pivotal,Phase 3 trials evaluating its lead ...ll primary endpoints. HZT-501, a novel, proprietar...ofen and famotidine, demonstrated a,statistically...roidal,anti-inflammatory drug (NSAID)-induced upp...
(Date:12/1/2008)...SNewswire/ -- New research has found that the avai...aphy (CT) scanner in an emergency room can signifi...eceive a potentially life-saving treatment. Result...enter (NSMC)-Salem Hospital in Salem, Mass., will ...diological Society of North America (RSNA). , ...
(Date:12/1/2008)...swire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Na..., one of the world,s leading medical journals, res...ulator, experimental compound tasimelteon (VEC-162...tled "Melatonin agonist tasimelteon (VEC-162) for ...domised controlled multicentre trials." Results ar...
(Date:12/1/2008).../ -- S*BIO Pte Ltd today announced the initiation ...and orally-active JAK2 inhibitor, in leading medic...idiopathic myelofibrosis (CIMF). , , The t...bility of SB1518 in patients with CIMF and is expe... of the study will assess the safety profile and e...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mechanism and function of humor identified by new evolutionary theory 3799 1Mechanism and function of humor identified by new evolutionary theory 3799 2Mechanism and function of humor identified by new evolutionary theory 3799 3Mechanism and function of humor identified by new evolutionary theory 3799 4ABC News NIGHTLINE Features HIFU with Sonablate 28R 29 500 as Non Invasive Treatment Option for Prostate Cancer 2536 1ABC News NIGHTLINE Features HIFU with Sonablate 28R 29 500 as Non Invasive Treatment Option for Prostate Cancer 2536 2ABC News NIGHTLINE Features HIFU with Sonablate 28R 29 500 as Non Invasive Treatment Option for Prostate Cancer 2536 3Michigan Health 26 Hospital Association Elects 2008 Officers and Board Members Bestows Awards 22883 1Michigan Health 26 Hospital Association Elects 2008 Officers and Board Members Bestows Awards 22883 2Michigan Health 26 Hospital Association Elects 2008 Officers and Board Members Bestows Awards 22883 3European Ministers Sign Groundbreaking Charter on Health System 22879 1European Ministers Sign Groundbreaking Charter on Health System 22879 2European Ministers Sign Groundbreaking Charter on Health System 22879 3
1 mm wide by 28 mm long sterling silver blade. Flat serrated handle with polished finish.
Double ended lasik spatula with flattened tip for lifting and smoothing the corneal flap. The sharp tip is useful to outline a previous flap in preparation for retreatment.
Serrated rake tip spatula with 20 gauge shaft. Black finish for reduced glare. Can be used with 20 gauge MVR blades.
Rounded tip spatula with 20 gauge shaft. Black finish for reduced glare.
Medicine Products: